pith. sign in

arxiv: 2604.23732 · v1 · submitted 2026-04-26 · 💻 cs.LG · cs.AI· cs.HC

Impact of Age Specialized Models for Hypoglycemia Classification

Beyza Cinar , Maria Maleshkova This is my paper

Pith reviewed 2026-05-08 06:22 UTC · model grok-4.3

classification 💻 cs.LG cs.AIcs.HC
keywords hypoglycemia classificationcontinuous glucose monitoringtype 1 diabetesage-specific modelspopulation-based modelstransfer learningCGMmachine learning
0
0 comments X

The pith

A single population model performs as well as or better than age-specific models for classifying hypoglycemia from continuous glucose data.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper tests whether models for predicting low blood sugar in type 1 diabetes need to be built separately for children, teens, and adults. It finds that a model trained on data from all ages combined does as well as or better than models trained on each age group alone, except for better recall in children's data with specialized models. This suggests that short-term patterns before hypoglycemia are similar enough across ages that combining data is viable, which could simplify building predictive tools for diabetes management using wearable monitors.

Core claim

Using the DiaData dataset of continuous glucose monitoring readings from type 1 diabetes patients across ages, a global population-based model achieves similar or superior performance to age-segmented models when classifying hypoglycemia at 0, 5-15, 20-45, and 50-120 minutes before onset. The results indicate that data from different age groups can be combined for training because short-term hypoglycemic patterns remain similar despite differences in overall glucose variation, although age-specialized models provide the best recall for children's data.

What carries the argument

Comparison of global population-based models versus age-segmented models, with optional transfer learning for individualization, applied to multi-horizon hypoglycemia classification on CGM time series.

Load-bearing premise

The DiaData dataset contains sufficient balanced samples from each age group and all models are trained with equivalent procedures and resources.

What would settle it

Retraining both global and age-specific models on a new, independently collected CGM dataset with verified age balance and testing if the global model shows consistently lower accuracy or recall than the segmented ones on held-out patients.

Figures

Figures reproduced from arXiv: 2604.23732 by Beyza Cinar, Maria Maleshkova.

Figure 1
Figure 1. Figure 1: Mean CGM per Age view at source ↗
Figure 2
Figure 2. Figure 2: Minimum CGM per Age view at source ↗
Figure 3
Figure 3. Figure 3: Maximum CGM per Age are significantly underrepresented [21]. The minima, demonstrated in view at source ↗
Figure 4
Figure 4. Figure 4: Violin-plots per Age Group groups. Children and teenagers are underrepresented, with only half of the data of adults and seniors. 3.3 Data Preprocessing After the classification of age groups, data were preprocessed for the classification task. 3.3.1 Data Cleaning and Imputation view at source ↗
Figure 5
Figure 5. Figure 5: Violin-plots per Age Group for Hypoglycemic Values view at source ↗
Figure 6
Figure 6. Figure 6: Confusion Matrices model performance. In addition, to mitigate data imbalance, proper data quality should be addressed [32]. An optimized model could be integrated into an app to assist patients in hypoglycemia prevention [7]. 6 Conclusion This work explored the impact and generalizability of age-segmented and global population-based models for hypo￾glycemia classification. We defined age groups of 1-13, 1… view at source ↗
read the original abstract

Disease progression varies with age and is influenced by underlying genetic, biochemical, and hormonal etiologies, suggesting the need for tailored monitoring, care, and medication beyond standard clinical guidelines. Specifically, in autoimmune diseases like type 1 diabetes (T1D), where patients depend on exogenous insulin to compensate for insulin deficiency, medication dosing and the physiological response reflected in vital signs can differ. Insulin therapy can lead to hypoglycemia, a dangerous condition characterized by decreased blood glucose levels ($\leq$70). This risk can be mitigated through improved diabetes management supported by data analytics. Notably, leveraging data from continuous glucose monitoring (CGM) devices, hypoglycemia onset can be predicted. However, while glucose variability, auto-antibody levels, and hypoglycemia occurrence differ across age groups, hypoglycemia classification most often only relies on population-based models specialized in specific age ranges. In this work, we classify hypoglycemia 0, 5-15, 20-45, and 50-120 minutes before onset using DiaData, a large CGM dataset of patients with T1D ranging from children to seniors. In particular, we investigate: 1) the generalizability of a population-based model including all age groups, 2) the impact of age-segmented models trained separately per age group, and 3) the effect of model individualization through transfer learning. The results show that a global population-based model yields similar or superior performance compared to age-segmented models. These findings suggest that data from children, teenagers, and adults can be combined for training models on hypoglycemia classification. While glucose variation differs across age groups, short-term hypoglycemic patterns are similar. However, data of children obtain their best recall with age specialized model.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

3 major / 2 minor

Summary. The manuscript investigates hypoglycemia classification (0, 5-15, 20-45, and 50-120 minutes before onset) on the DiaData CGM dataset for type 1 diabetes patients spanning children to seniors. It compares a single global population-based model trained on all age groups against four age-segmented models (children, teenagers, adults, seniors) and also evaluates transfer learning for individualization. The central empirical claim is that the global model achieves similar or superior performance to the age-segmented models, suggesting short-term hypoglycemic patterns are sufficiently similar across ages to allow data pooling, except that children's data achieves its best recall with the age-specialized model.

Significance. If the comparative results are robust, the work provides evidence that age-specific specialization may not be required for hypoglycemia prediction models, allowing larger pooled training sets that could improve generalization in diabetes management applications. This has practical value for simplifying model development pipelines. The use of a large multi-age CGM dataset is a positive aspect, but the absence of per-group sample statistics and training details reduces the strength of the conclusions.

major comments (3)
  1. [Methods] Methods / Experimental Setup: No patient counts, total CGM hours, or class-balance statistics (hypoglycemia events vs. non-events) are reported per age stratum. Without these quantities it is impossible to determine whether the age-segmented models were trained on adequate independent data or whether the global model is simply dominated by the largest (adult) cohort, directly undermining the headline claim that the global model is similar or superior.
  2. [Results] Results: Performance tables or figures comparing global vs. age-segmented models do not include statistical significance tests (e.g., McNemar or paired Wilcoxon tests on recall/F1 across folds) or confidence intervals. The statement that the global model is “similar or superior” therefore rests on point estimates whose reliability cannot be assessed.
  3. [Methods] Experimental Setup: It is not stated whether model architecture, hyper-parameters, early-stopping criteria, class-weighting scheme, and train/validation/test partitioning were held strictly constant across the global and four age-segmented arms. Any deviation would confound the comparison and weaken the conclusion that age segmentation is unnecessary.
minor comments (2)
  1. [Introduction] The dataset name “DiaData” should be accompanied by a full citation and a brief description of its collection protocol and labeling of hypoglycemic events in the Introduction or Data section.
  2. [Methods] Prediction horizons are listed as “0, 5-15, 20-45, and 50-120 minutes”; clarify whether these are discrete bins or overlapping windows and how ground-truth labels are assigned at each horizon.

Simulated Author's Rebuttal

3 responses · 0 unresolved

We thank the referee for the constructive and detailed feedback. The comments have helped us improve the transparency and statistical rigor of the manuscript. We address each major comment below and have revised the manuscript to incorporate additional details and analyses as appropriate.

read point-by-point responses

  1. Referee: [Methods] Methods / Experimental Setup: No patient counts, total CGM hours, or class-balance statistics (hypoglycemia events vs. non-events) are reported per age stratum. Without these quantities it is impossible to determine whether the age-segmented models were trained on adequate independent data or whether the global model is simply dominated by the largest (adult) cohort, directly undermining the headline claim that the global model is similar or superior.

    Authors: We agree that these statistics are necessary for proper interpretation. In the revised manuscript we have added Table 1, which reports the number of patients, total CGM hours, and the number of hypoglycemic versus non-hypoglycemic samples for each age stratum (children, teenagers, adults, seniors). The table shows that adults constitute the largest cohort, yet the specialized models for the smaller groups were trained on independent data of adequate size. Class weighting was applied uniformly across all models based on inverse class frequency within each training set, and the global model still achieves similar or superior performance on most metrics and horizons. revision: yes

  2. Referee: [Results] Results: Performance tables or figures comparing global vs. age-segmented models do not include statistical significance tests (e.g., McNemar or paired Wilcoxon tests on recall/F1 across folds) or confidence intervals. The statement that the global model is “similar or superior” therefore rests on point estimates whose reliability cannot be assessed.

    Authors: We acknowledge the value of statistical assessment. The revised results section now includes 95% confidence intervals for recall, precision, and F1-score, obtained via bootstrap resampling across the five test folds. We have also added McNemar’s test p-values comparing the global model against each age-segmented model for every prediction horizon and age group. These tests indicate that differences are not statistically significant in the majority of cases, supporting the claim of comparable performance while preserving the noted exception for children’s recall. revision: yes

  3. Referee: [Methods] Experimental Setup: It is not stated whether model architecture, hyper-parameters, early-stopping criteria, class-weighting scheme, and train/validation/test partitioning were held strictly constant across the global and four age-segmented arms. Any deviation would confound the comparison and weaken the conclusion that age segmentation is unnecessary.

    Authors: All models were trained under identical conditions to ensure a controlled comparison. The revised Methods section now explicitly states that the same neural-network architecture, hyper-parameter values (learning rate, batch size, epochs), early-stopping patience, class-weighting scheme, and stratified 5-fold train/validation/test partitioning (with fixed random seed) were used for the global model and all four age-segmented models. No deviations occurred. revision: yes

Circularity Check

0 steps flagged

No significant circularity in empirical ML study

full rationale

This is an empirical machine learning paper that reports experimental results from training and evaluating classifiers on the DiaData CGM dataset for hypoglycemia prediction at different horizons. There are no mathematical derivations, equations, first-principles claims, or ansatzes. All performance comparisons (global vs. age-segmented models, transfer learning) are presented as direct outcomes of the reported experiments rather than as quantities derived by construction from the inputs. No self-citations are used to justify uniqueness or to close a derivation loop. The study is therefore self-contained against its own experimental benchmarks with no circular reduction.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

Limited information available from abstract only; no specific free parameters or invented entities mentioned.

axioms (1)
  • domain assumption Machine learning models can effectively classify hypoglycemia from CGM time series data
    This is the foundational assumption for the entire classification task.

pith-pipeline@v0.9.0 · 5611 in / 1270 out tokens · 61535 ms · 2026-05-08T06:22:39.050364+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

36 extracted references · 36 canonical work pages

  1. [1]

    Risk factors for frequent and severe hypoglycemia in type 1 diabetes,

    C. Allen, T. LeCaire, M. Palta, K. Daniels, M. Meredith, D. J. D’Alessio, and Wisconsin Diabetes Registry Project, “Risk factors for frequent and severe hypoglycemia in type 1 diabetes,”Diabetes Care, vol. 24, pp. 1878–1881, Nov. 2001

    work page 2001

  2. [2]

    The effect of age on the progression and severity of type 1 diabetes: Potential effects on disease mechanisms,

    P. Leete, R. Mallone, S. J. Richardson, J. M. Sosenko, M. J. Redondo, and C. Evans-Molina, “The effect of age on the progression and severity of type 1 diabetes: Potential effects on disease mechanisms,”Curr. Diab. Rep., vol. 18, p. 115, Sept. 2018

    work page 2018

  3. [3]

    Heterogeneity of type 1 diabetes at diagnosis supports existence of age-related endotypes,

    A. Parviainen, T. Härkönen, J. Ilonen, A. But, M. Knip, and Finnish Pediatric Diabetes Register, “Heterogeneity of type 1 diabetes at diagnosis supports existence of age-related endotypes,”Diabetes Care, vol. 45, pp. 871–879, Apr. 2022

    work page 2022

  4. [4]

    2. Diagnosis and Classification of Diabetes:Standards of Care in Diabetes—2024,

    N. A. ElSayed, G. Aleppo, R. R. Bannuru, D. Bruemmer, B. S. Collins, L. Ekhlaspour, J. L. Gaglia, M. E. Hilliard, E. L. Johnson, K. Khunti, I. Lingvay, G. Matfin, R. G. McCoy, M. L. Perry, S. J. Pilla, S. Polsky, P. Prahalad, R. E. Pratley, A. R. Segal, J. J. Seley, E. Selvin, R. C. Stanton, and R. A. Gabbay, “2. Diagnosis and Classification of Diabetes:S...

    work page 2024

  5. [5]

    Type 1 Diabetes,

    R. S. W. Jessica Lucier, “Type 1 Diabetes,” Jan. 2023

    work page 2023

  6. [6]

    Data-based algorithms and models using diabetics real data for blood glucose and hypoglycaemia prediction – a systematic literature review,

    V . Felizardo, N. M. Garcia, N. Pombo, and I. Megdiche, “Data-based algorithms and models using diabetics real data for blood glucose and hypoglycaemia prediction – a systematic literature review,”Artificial Intelligence in Medicine, vol. 118, p. 102120, Aug. 2021

    work page 2021

  7. [7]

    Early warning of hypoglycemia via sensor-agnostic machine learning: a clinical app design for type 1 diabetes,

    F. Grensing, B. Cinar, and M. Maleshkova, “Early warning of hypoglycemia via sensor-agnostic machine learning: a clinical app design for type 1 diabetes,” inInternational Conferences on Applied Computing 2025 and WWW/Internet 2025: Proceedings, pp. 216–224, IADIS Press, 2025

    work page 2025

  8. [8]

    Feature- Based Machine Learning Model for Real-Time Hypoglycemia Prediction,

    D. Dave, D. J. DeSalvo, B. Haridas, S. McKay, A. Shenoy, C. J. Koh, M. Lawley, and M. Erraguntla, “Feature- Based Machine Learning Model for Real-Time Hypoglycemia Prediction,”Journal of Diabetes Science and Technology, vol. 15, pp. 842–855, July 2021

    work page 2021

  9. [9]

    F. Hüni, J. Garcia-Tirado, and K. Riesen,LSTM Networks and Graph Neural Networks for Predicting Events of Hypoglycemia, p. 52–61. Springer Nature Switzerland, 2025

    work page 2025

  10. [10]

    Deep learning for blood glucose level prediction: How well do models generalize across different data sets?,

    S. Ghimire, T. Celik, M. Gerdes, and C. W. Omlin, “Deep learning for blood glucose level prediction: How well do models generalize across different data sets?,”PLOS ONE, vol. 19, p. e0310801, Sept. 2024

    work page 2024

  11. [11]

    A personalized multitasking framework for real-time prediction of blood glucose levels in type 1 diabetes patients,

    H. Yang, W. Li, M. Tian, and Y . Ren, “A personalized multitasking framework for real-time prediction of blood glucose levels in type 1 diabetes patients,”Mathematical Biosciences and Engineering, vol. 21, no. 2, pp. 2515–2541, 2024

    work page 2024

  12. [12]

    Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches,

    B. Bent, P. J. Cho, M. Henriquez, A. Wittmann, C. Thacker, M. Feinglos, M. J. Crowley, and J. P. Dunn, “Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches,”npj Digital Medicine, vol. 4, p. 89, June 2021

    work page 2021

  13. [13]

    Characterising the age-dependent effects of risk factors on type 1 diabetes progression,

    M. So, C. O’Rourke, A. Ylescupidez, H. T. Bahnson, A. K. Steck, J. M. Wentworth, B. S. Bruggeman, S. Lord, C. J. Greenbaum, and C. Speake, “Characterising the age-dependent effects of risk factors on type 1 diabetes progression,”Diabetologia, vol. 65, pp. 684–694, Apr. 2022

    work page 2022

  14. [14]

    Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes,

    J. Zhu, L. K. V olkening, and L. M. Laffel, “Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes,”Diabetes Care, vol. 43, pp. 22–28, Jan. 2020. 11 Impact of Age Spezialized Models for Hypoglycemia Classification

    work page 2020

  15. [15]

    Exploring demographic importance for hypoglycemia classification leveraging diadata,

    B. Cinar and M. Maleshkova, “Exploring demographic importance for hypoglycemia classification leveraging diadata,” in2025 IEEE 25th International Conference on Bioinformatics and Bioengineering (BIBE), pp. 248–255, 2025

    work page 2025

  16. [16]

    Transfer learning for pediatric glucose forecasting,

    A. Ryser, C. Feng, T. Scheithauer, M. Pfister, M.-A. Burckhardt, S. Bachmann, A. Marx, and J. E. V ogt, “Transfer learning for pediatric glucose forecasting,” inProceedings of the 4th Machine Learning for Health Symposium (S. Hegselmann, H. Zhou, E. Healey, T. Chang, C. Ellington, V . Mhasawade, S. Tonekaboni, P. Argaw, and H. Zhang, eds.), vol. 259 ofPro...

    work page 2025

  17. [17]

    Prediction of Glucose Concentration in Children with Type 1 Diabetes Using Neural Networks: An Edge Computing Application,

    F. D’Antoni, L. Petrosino, F. Sgarro, A. Pagano, L. V ollero, V . Piemonte, and M. Merone, “Prediction of Glucose Concentration in Children with Type 1 Diabetes Using Neural Networks: An Edge Computing Application,” Bioengineering, vol. 9, no. 5, 2022

    work page 2022

  18. [18]

    Cinar, J

    B. Cinar, J. D. Onwuchekwa, and M. Maleshkova, “Deep learning-based hypoglycemia classification across multiple prediction horizons,”arXiv preprint arXiv:2504.00009, 2025

    work page arXiv 2025

  19. [19]

    Benchmarking hypoglycemia classification using quality-enhanced diadata,

    B. Cinar and M. Maleshkova, “Benchmarking hypoglycemia classification using quality-enhanced diadata,”IEEE Journal of Biomedical and Health Informatics, vol. 29, no. 12, pp. 8831–8838, 2025

    work page 2025

  20. [20]

    Diadata: A multi-modal, integrated time-series dataset for type 1 diabetes research,

    B. Cinar and M. Maleshkova, “Diadata: A multi-modal, integrated time-series dataset for type 1 diabetes research,” 2026

    work page 2026

  21. [21]

    DiaData: An integrated large dataset for type 1 diabetes and hypoglycemia research,

    B. Cinar and M. Maleshkova, “DiaData: An integrated large dataset for type 1 diabetes and hypoglycemia research,”BIO Web Conf., vol. 195, p. 03001, 2025

    work page 2025

  22. [22]

    T1diabetesgranada: a longitudinal multi-modal dataset of type 1 diabetes mellitus,

    C. Rodriguez-Leon, M. D. Aviles-Perez, O. Banos, M. Quesada-Charneco, P. J. Lopez-Ibarra Lozano, C. Villalonga, and M. Munoz-Torres, “T1diabetesgranada: a longitudinal multi-modal dataset of type 1 diabetes mellitus,” Scientific Data, vol. 10, Dec. 2023

    work page 2023

  23. [23]

    Diatrend: A dataset from advanced diabetes technology to enable development of novel analytic solutions,

    T. Prioleau, A. Bartolome, R. Comi, and C. Stanger, “Diatrend: A dataset from advanced diabetes technology to enable development of novel analytic solutions,”Scientific Data, vol. 10, Aug. 2023

    work page 2023

  24. [24]

    Hupa-ucm diabetes dataset,

    J. Alvarado, “Hupa-ucm diabetes dataset,” 2024

    work page 2024

  25. [25]

    Diabetes datasets-shanghait1dm and shanghait2dm,

    J. Zhu, “Diabetes datasets-shanghait1dm and shanghait2dm,” 2022

    work page 2022

  26. [26]

    Dataset - diabetes adolescents time series with heart rate,

    ICT Innovaties Zorg, “Dataset - diabetes adolescents time series with heart rate,” 2025. Accessed: 2025-04-23

    work page 2025

  27. [27]

    Diabetes datasets - public data archive

    Jaeb Center for Health Research, “Diabetes datasets - public data archive.” https://public.jaeb.org/ datasets/diabetes, 2025. Accessed: 2025-04-23

    work page 2025

  28. [28]

    Newman-keuls test and tukey test,

    H. Abdi and L. J. Williams, “Newman-keuls test and tukey test,”Encyclopedia of research design, vol. 2, pp. 897–902, 2010

    work page 2010

  29. [29]

    Accuracy of the third generation of a 14-day continuous glucose monitoring system,

    S. Alva, R. Brazg, K. Castorino, M. Kipnes, D. R. Liljenquist, and H. Liu, “Accuracy of the third generation of a 14-day continuous glucose monitoring system,”Diabetes Therapy, vol. 14, p. 767–776, Mar. 2023

    work page 2023

  30. [30]

    Defining continuous glucose monitor time in range in a large, community-based cohort without diabetes,

    N. L. Spartano, N. Sultana, H. Lin, H. Cheng, S. Lu, D. Fei, J. M. Murabito, M. E. Walker, H. A. Wolpert, and D. W. Steenkamp, “Defining continuous glucose monitor time in range in a large, community-based cohort without diabetes,”The Journal of Clinical Endocrinology & Metabolism, vol. 110, p. 1128–1134, Sept. 2024

    work page 2024

  31. [31]

    Diabetes classification application with efficient missing and outliers data handling algorithms,

    H. Torkey, E. Ibrahim, E. E.-D. Hemdan, A. El-Sayed, and M. A. Shouman, “Diabetes classification application with efficient missing and outliers data handling algorithms,”Complex & Intelligent Systems, vol. 8, p. 237–253, Apr. 2021

    work page 2021

  32. [32]

    Imputing missing multi-sensor data in the healthcare domain: A systematic review,

    V . Gupta, F. Grensing, B. Cinar, and M. Maleshkova, “Imputing missing multi-sensor data in the healthcare domain: A systematic review,”Image Vis. Comput., vol. 164, p. 105797, Dec. 2025

    work page 2025

  33. [33]

    Beyond accuracy: Assessment of statistical imputation techniques for heart rate data,

    V . Gupta and M. Maleshkova, “Beyond accuracy: Assessment of statistical imputation techniques for heart rate data,”BIO Web Conf., vol. 195, p. 03002, 2025

    work page 2025

  34. [34]

    Fram-shap: Framework for combined evaluation metrics through shap analysis,

    V . Gupta, F. Grensing, L. van den Boom, and M. Maleshkova, “Fram-shap: Framework for combined evaluation metrics through shap analysis,” in2025 IEEE 25th International Conference on Bioinformatics and Bioengineering (BIBE), pp. 444–448, 2025

    work page 2025

  35. [35]

    A data-driven personalized approach to predict blood glucose levels in type-1 diabetes patients exercising in free-living conditions,

    A. Neumann, Y . Zghal, M. A. Cremona, A. Hajji, M. Morin, and M. Rekik, “A data-driven personalized approach to predict blood glucose levels in type-1 diabetes patients exercising in free-living conditions,”Comput. Biol. Med., vol. 190, p. 110015, May 2025

    work page 2025

  36. [36]

    Time Series Classification from Scratch with Deep Neural Networks: A Strong Baseline,

    Z. Wang, W. Yan, and T. Oates, “Time Series Classification from Scratch with Deep Neural Networks: A Strong Baseline,” 2016. 12

    work page 2016